Keen Vision Acquisition Corporation Ordinary Shares
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Ka Chun Wong
- Full Time Employees
- 2
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 37 Greenbriar Drive Summit NJ United States of America 07901
- IPO Date
- Sep 15, 2023
- CIK
- 0001889983
- Website
- kv-ac.com
- Similar Companies
- Business
- Keen Vision Acquisition Corporation Keen Vision Acquisition Corporation Ordinary Shares (KVAC) is a blank check company, or special purpose acquisition company (SPAC), incorporated in the British Virgin Islands in 2021 and headquartered in Summit, New Jersey. The company has no significant current operations and focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more target businesses, with a primary emphasis on opportunities in biotechnology, consumer goods, and agriculture sectors evaluated through sustainability and environmental, social, and corporate governance (ESG) criteria. It offers public market access to private companies via its structured transaction platform, targeting global opportunities without geographic restrictions. Recently, KVAC announced a merger agreement with Medera Inc. in September 2024, aiming to list the combined entity on Nasdaq in Q4 2024 subject to shareholder approval and customary conditions; extended its business combination deadline multiple times, including to July 27, 2025 via monthly trust deposits and a nine-month extension agreement with sponsor KVC Sponsor LLC; and issued unsecured promissory notes to its sponsor, such as $144,670 on November 18, 2025 and $200,000 earlier, convertible into units at $10 upon closing a business combination.
Financial Comparison: Blaize (NASDAQ:BZAI) and Keen Vision Acquisition (NASDAQ:KVAC)
Keen Vision Acquisition (NASDAQ:KVAC) Shares Up 0.9% – Here’s What Happened
65,256 Shares in Keen Vision Acquisition Corporation $KVAC Acquired by Crossingbridge Advisors LLC
Keen Vision Acquisition (NASDAQ:KVAC) Stock Price Up 0.1% – Time to Buy?
Keen Vision Acquisition (NASDAQ:KVAC) Trading 0.5% Higher – Still a Buy?
Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025
Medera to Present Late-Breaking Phase 1/2a Clinical Trial Results at Heart Failure 2025 Congress
Medera Presented Updated Results from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at 2025 HFpEF Summit
Medera Receives DSMB Clearance to Initiate Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial for SRD-001 Gene Therapy in Heart Failure with Reduced Ejection Fraction
Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction
Medera's Novoheart Expands Human Cardiac Research with CTScreen™ Installation at University Medical Center, Utrecht
Medera, Inc. to Participate in Two Upcoming Investor Conferences
Medera Announces Publication of Study Utilizing Machine Learning to Enhance Next-Generation Drug Screening with Human mini-Heart Technology
Medera Announces Completion of Cohort A and Initiation of Dosing in Cohort B of MUSIC-HFpEF, a Phase 1/2a Clinical Trial Evaluating First-In-Human Gene Therapy SRD-002 for Heart Failure with Preserved Ejection Fraction
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Keen Vision Acquisition Corp. - KVAC
Medera Inc. to be Listed on NASDAQ Through a Merger Agreement with Keen Vision Acquisition Corporation
Keen Vision Acquisition Corporation Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing September 15, 2023